Cargando…
Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial
BACKGROUND: There is an urgent need to develop additional treatment strategies for patients with treatment-resistant depression (TRD). The rapid but short-lived antidepressant effects of intravenous (IV) ketamine as a racemic mixture have been shown repeatedly in this population, but there is still...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884875/ https://www.ncbi.nlm.nih.gov/pubmed/31783823 http://dx.doi.org/10.1186/s12888-019-2359-1 |